Medicure Inc. (TSXV:MPH)

Medicure Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.83	3.84	7.19	6.37	4.86	3.69
Cash & Short-Term Investments	1.83	3.84	7.19	6.37	4.86	3.69
Cash Growth	-61.34%	-46.67%	12.91%	31.13%	31.48%	36.01%
Accounts Receivable	4.65	4.72	5.26	4.43	5.53	4.59
Other Receivables	0.08	0.1	0.04	0.37	0.11	0.07
Receivables	4.73	4.82	5.3	4.79	5.64	4.66
Inventory	3.51	2.94	3.28	2.9	3.22	3.33
Prepaid Expenses	0.35	0.29	0.13	1.14	1.13	0.87
Restricted Cash	-	-	-	-	-	0
Total Current Assets	10.42	11.89	15.9	15.21	14.85	12.55
Property, Plant & Equipment	0.74	0.95	0.96	0.74	1.19	1.61
Goodwill	4.42	4.26	3.38	3.1	3.18	2.97
Other Intangible Assets	6.91	7.75	9.35	8.94	10.62	11.21
Other Long-Term Assets	0.11	0.11	0.1	0.08	0.06	0.06
Total Assets	22.59	24.95	29.68	28.06	29.9	28.41

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.07	10.48	7.9	7.54	6.51	6.49
Accrued Expenses	0.25	0.11	0.03	0.07	0.8	0.6
Current Portion of Leases	0.43	0.46	0.37	0.32	0.35	0.38
Current Income Taxes Payable	0.01	0.09	0.1	0.02	0.06	0.11
Other Current Liabilities	-	0.47	-	-	0.68	0.93
Total Current Liabilities	10.75	11.61	8.4	7.93	8.39	8.51
Long-Term Leases	0.27	0.43	0.51	0.23	0.5	0.79
Other Long-Term Liabilities	-	-	-	-	-	0.7
Total Liabilities	11.02	12.04	8.9	8.16	8.89	10

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	81.01	81.01	81.01	81.01	80.92	80.92
Additional Paid-In Capital	11.05	11.06	10.92	10.72	10.48	10.43
Retained Earnings	-75.82	-73.99	-66.89	-65.85	-64.93	-66.3
Comprehensive Income & Other	-4.67	-5.17	-4.26	-5.99	-5.46	-6.64
Total Common Equity	11.57	12.91	20.78	19.9	21.01	18.41
Shareholders' Equity	11.57	12.91	20.78	19.9	21.01	18.41
Total Liabilities & Equity	22.59	24.95	29.68	28.06	29.9	28.41

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.7	0.89	0.87	0.54	0.85	1.17
Net Cash (Debt)	1.14	2.94	6.32	5.83	4.01	2.53
Net Cash Growth	-68.85%	-53.40%	8.45%	45.33%	58.73%	98.98%
Net Cash Per Share	0.11	0.28	0.61	0.56	0.38	0.25
Filing Date Shares Outstanding	10.44	10.44	10.44	10.44	10.3	10.25
Total Common Shares Outstanding	10.44	10.44	10.44	10.44	10.25	10.25
Working Capital	-0.34	0.27	7.5	7.27	6.46	4.04
Book Value Per Share	1.11	1.24	1.99	1.91	2.05	1.80
Tangible Book Value	0.24	0.9	8.05	7.85	7.2	4.23
Tangible Book Value Per Share	0.02	0.09	0.77	0.75	0.70	0.41
Machinery	-	1.06	0.99	0.93	0.95	0.91
Leasehold Improvements	-	0.18	0.18	0.18	0.18	0.18

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error